baber/WOPTO huggingface dataset:
Patent MY-173322-A (MY)
Title: Serum infection markers for diagnosis of toxoplasmosis
Inventor: RAHMAH BINTI NOORDIN
IPC: G01N33/68
Filed: 2010-01-11
Abstract: The invention relates to a method in diagnosing the disease toxoplasmosis in human patients using serum infection markers. The infection markers were identified using unfractionated and fractionated serum samples (depleted of 14 serum abundant proteins) and techniques of two-dimensional gel electrophoresis, Western blot, mass spectrometry and affinity chromatography. Among proteins which have been identified were two host specific proteins and five parasite-specific proteins. These serum infection markers from samples of patients with evidence of active toxoplasmosis can serve as antigen detection test(s) for toxoplasmosis diagnosis.
Patent MY-167216-A (MY)
Title: Kinase inhibitors
Inventor: VAN NIEL MONIQUE BODIL
IPC: C07D471/04
Filed: 2012-12-05
Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof: Wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
Patent MY-180809-A (MY)
Title: Cleaning a plurality of needles, post manufacture and before assembly into a syringe, cannula and the like
Inventor: ZHAO LIANG
Filed: 2013-05-31
Abstract: A system for cleaning a plurality of needles, the system comprising: a conveyor for conveying a plurality of jigs through a series of stations, each jig arranged to contain at least some of said needles; said stations including: a pre-treatment station (85) for the removal of detritus from said needles; an electronic polishing station; a post-treatment station (25) for removal of material from the surface of said treated needles; a cleaning station for cleaning said needles; a drying station and; an unloading station for unloading said needles from said jigs. (Figure 2)
Patent MY-186085-A (MY)
Title: Linguistic features in short messaging service (sms) apologies
Inventor: Ernisa Marzuki
IPC: G06F7/00
Filed: 2014-03-06
Abstract: Disclosed is a method and system for a sociopragmatic coding scheme which can be applied to classify sociopragmatic strategies applied to apologies in general, especially in Malay, and an SMS coding scheme which can be applied to code SMS apologies sent in Malay and English. The system for providing a sociopragmatic coding scheme for categorizing a plurality of strategies to compose at least one information in a messaging system (102) comprises a portable mobile communication device (104) capable of sending and/or receiving a plurality of information from at least one user, the plurality of information being provided in a combination of a first language and a second language of the user. The sociopragmatic coding scheme enables categorization of the plurality of strategies to compose and send the message at a plurality of situations. A plurality of words relative to at least one situation is suggested by the SMS coding scheme. (Figure 3)
Patent MY-180505-A (MY)
Title: A method of continuous high pressure sterilization of oil palm fruits
Inventor: HONG NGIT MING
IPC: C11B1/16
Filed: 2015-02-17
Abstract: A method of continuous sterilization of oil palm fruit bunches (FFB) under high steam pressure (16) and temperature at constant levels. A screw conveyor (23) inside the sterilizing vessel (15) constantly rotate and churns the FFB mass forward. This tillage of the FFB improves the steam penetration into the FFB mass, reducing incidence of uncooked fruits. Sterilization is completed when the FFB mass reaches the end of the sterilizing vessel (15). The invention is suited for an automated palm oil mill operations in real time. Advantages are, faster cooking time, less steam consumption, improved oil extraction rate and low oil loss, improved oil quality, and reduced costs and manpower.
Patent MY-169039-A (MY)
Title: Post-treatment of deboronated mww zeolite
Inventor: GERLACH OLGA
Filed: 2013-10-09
Abstract: A process for the post-treatment of a zeolitic material having an MWW framework structure, the process comprising (i) providing a zeolitic material having an wrNW framework structure, wherein the framework structure of the zeofitic material comprises X20 3 and Y02, wherein Y is a tetravalent element and X is a trivalent element and wherein the molar ratio X20 3  :  Y0 2 is greater than 0.02 : 1; (ii) treating the zeolitic material provided in (i) with a liquid solvent system thereby obtaining a zeolitic material having a molar ratio X20 3 : Y0 2 of at most 0.02 :  1,  and at least partially separating the zeolitic material from the liquid solvent system;  (iii)  treating the zeolitic material obtained from  (ii) with a liquid aqueous system having a pH in the range of 5.5 to 8 and a temperature of at least 75 ?C.  (No suitable figure)
Patent MY-183713-A (MY)
Title: Process for the production of dialkyl succinate
Inventor: SMIDT MARTIN LUCAS
Filed: 2014-12-02
Abstract: A process for the production of dialkyl succinate from a bio-succinic acid feedstock comprising the steps of: feeding bio-succinic acid to a point at or near the bottom of a reaction distillation zone column operated at temperatures and pressures to enable esterification of the succinic acid and passing said stream co-currently with upflowing alkanol such that said esterification reaction occurs: removing an overhead vapour stream from at or near the top of the reaction distillation zone column comprising diester, alkanol, water of esterification and organic components and passing said stream to an alkanol separation column where the alkanol is separated from the water of esterification and from the organic components; removing a side draw from the alkanol separation column from a point below the feed point thereto, said side draw comprising partially immiscible organic and aqueous phases; passing said side draw to phase separation apparatus where the partially immiscible organic and aqueous phases are separated; passing said organic phase to a column where the dialkyl succinate is separated from residual water and other organic components; and recovering the dialkyl succinate.  Figure 1
Patent MY-174648-A (MY)
Title: Formulations of organic compounds
Inventor: KOCHHAR CHARU
Filed: 2014-03-04
Abstract: The present invention relates to solid pharmaceutical compositions compnsmg the phosphatidylinositol 3-kinase inhibitor compound 4-(trifluoromethyl)-5-(2,6- dimorpholinopyrimidin-4-yl)pyridin-2-amine or a pharmaceutically acceptable salt thereof, sodium stearyl fumarate, and optionally at least one additional pharmaceutically acceptable carrier. The present invention also relates to the processes for their preparation and to their use as medicaments for the treatment of cancer.
Patent MY-178539-A (MY)
Title: Method for producing a textile sheet heating element
Inventor: ROLF SCHUMACHER
Filed: 2014-07-03
Abstract: The invention relates to a method of producing a textile flat heating element (1), wherein a knitted material is formed and, in one and the same working procedure, the heat conductors (4) are laid as warp threads by knitting. Contact lines (5) contacting the heat conductors (4) are incorporated at mutual spacings as weft threads or weft thread groups. A warp knitting machine or Raschel machine which comprises a magazine weft intake system with feed chains (1) for the feed of weft threads and a weft carriage (12) for insertion of weft threads , is used for producing the flat heating element (1). The production rate of the warp knitting machine or Raschel machine is varied in dependence on the mesh formation and only the feed chain (11), but also the weft carriage (12) are synchronously stopped for predetermined times depending on the mesh formation.
Patent MY-183427-A (MY)
Title: A method for producing 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine
Inventor: TAKENAKA HIROSHI
Filed: 2014-12-16
Abstract: The present invention involves preparing compounds represented by the formula. (In the formula: R1 represents a Br group, an iodine group, a Cl group, an NO2 group, or an NH2 group; R2 represents a halogen group, an NO2 group, an NH2 group, Sn (R6) 3, N=N-NR7R8, OSO2R9, N R10R11, phenyliodonium, a heterocyclic group iodine, boric acid, or a borate ester; R30 represents a protective group PG1 ; R40 or R50 represent hydrogen, a protective group PG2, or C6Hs ( C6Hs) C=N, wherein NR40R50 are together.)     No figure
Patent MY-177957-A (MY)
Title: The preparation of caprolactam from 6-amino caproic acid obtained in a fermentation process
Inventor: GUIT RUDOLF PHILIPPUS MARIA
Filed: 2010-12-22
Abstract: The invention relates to a method for preparing caprolactam comprising recovering a mixture containing 6-aminocaproic acid, from a culture medium comprising biomass, and thereafter cyclising the 6-aminocaproic acid in the presence of superheated steam, thereby forming caprolactam, wherein the weight to weight ratio carbohydrate to 6-aminocaproic acid in said mixture is 0.03 or less.
Patent MY-196178-A (MY)
Title: Method And Nodes For Integrating Networks
Inventor: CHEN PING
IPC: H04W12/06
Filed: 2015-04-15
Abstract: The embodiments herein relate to a method performed by an AAA server (113) for enabling a non-SIM device (101b) to access a first network (100a) via a second network (100b). Based on a request for authorization to the first network (100a) from the non-SIM device (101b), the AAA server (113) obtains an identity associated with the non-SIM device (101b). The AAA server (113) transmits a request for a user profile associated with a user of the non-SIM device (101b) to the subscriber database (110). The request comprises the obtained identity for the non-SIM device (101b). The AAA server (113) receives, from the subscriber database (110), the requested user profile for the non-SIM device (101b). Based on the received user profile, the AAA server (113) authorizes the non-SIM device (101b) to access the first network (100a) via the second network (100b).
Patent MY-188879-A (MY)
Title: Glycan therapeutics and related methods thereof
Inventor: VON MALTZAHN GEOFFREY A
IPC: A61K31/702
Filed: 2016-01-13
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
Patent MY-188348-A (MY)
Title: Single-molecule sequencing of plasma dna
Inventor: LO YUK-MING DENNIS
IPC: C12Q1/68
Filed: 2016-08-12
Abstract: Embodiments may include a method of determining a nucleic acid sequence. The method may include receiving a plurality of DNA fragments. The method may also include concatemerizing a first set of the DNA fragments to obtain a concatemer. The method may include performing single-molecule sequencing of the concatemer to obtain a first sequence of the concatemer. In some embodiments, single-molecule sequencing may be performed using a nanopore, and the method may include passing the concatemer through a nanopore. A first electrical signal may then be detected as the concatemer passes through the nanopore. The first electrical signal may correspond to a first sequence of the concatemer. In addition, the method may include analyzing the first electrical signal to determine the first sequence. Subsequences of the first sequence may be aligned to identify sequences corresponding to each of the first set of the DNA fragments.p
Patent MY-195896-A (MY)
Title: An Implant
Inventor: VALLITTU PEKKA
IPC: A61F2/30
Filed: 2016-07-01
Abstract: The present invention relates to an implant consisting of a surface layer (4, 8) consisting of fibres and a matrix, having a first surface and a second surface opposite each other, and having a thickness that is at most 5 % of the largest dimension of said surface layer; a porous biodegradable part (5) having a first surface and a second surface opposite each other, wherein its first surface is attached to the second surface of the surface layer and having a thickness of 1 - 8 mm; and a membrane layer (6) made of collage having a first surface and a second surface opposite each other, wherein its first surface is attached to the second surface of the porous part without covering the edges of the porous part; wherein its first surface is attached to the second surface of the porous part wherein the porous part comprises material selected from the group consisting of bioactive glass, bioactive ceramic, hydroxyapatite, tricalciumphosphate and mixtures thereof.
Patent MY-193626-A (MY)
Title: Sanitary evaporator assembly
Inventor: KNATT KEVIN
IPC: F25C1/12
Filed: 2017-11-21
Abstract: An ice maker evaporator assembly (100) having an evaporator pan (120) with a back wall (300) and left, right, top and bottom sidewalls (310, 320, 330, 340) extending from the back wall, and a freeze plate located within the evaporator pan. A serpentine tubing (200) is thermally coupled to the back wall of the evaporator pan opposite the left, right, top and bottom sidewalls. A first layer of insulation is formed on the serpentine tubing. An evaporator housing having a housing back wall (180) and housing left, right, top and bottom sidewalls (160, 170, 140, 150) extending from the housing back wall is attached to the evaporator pan and covers serpentine tubing. A second layer of insulation is formed on top of the first layer of insulation.  FIGURE 1
Patent MY-197447-A (MY)
Title: Pulley structure
Inventor: SHIMAMURA HAYATO
IPC: F16H55/36
Filed: 2018-04-17
Abstract: The present invention relates to a pulley structure ( 1) equipped with an outer rotating body (2), an inner rotating body (3), and a coil spring (4) provided between the outer rotating body (2) and the inner rotating body (3). The coil spring (4) is configured so as to undergo torsional deformation in a diameter-expanding or a diameter-contracting direction, thereby engaging the outer rotating body (2) and the inner rotating body (3) and transmitting torque, and to undergo torsional deformation in the direction opposite the direction in which torque is transmitted, thereby entering a disengaged state in which the coil spring slides with the outer rotating body (2) or the inner rotating body (3), thus interrupting the transmission of torque. The number of windings of the coil spring (4) is in a range between [M - 0.125] and M (both inclusive), where Mis a natural number.  Figure 1
Patent SG-10201407096R-A (SG)
Title: Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
Inventor: COSTANTINO PAOLO
Filed: 2010-11-01
Abstract: Abstract PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES The invention provides method a for releasing capsular polysaccharide from S.aureus type 5 or type 8 cells, comprising the step of treating the celis with acid. The invention further provides process a for purifying capsular polysaccharide from S.aureus type 5 or type 8 cells comprising this method. Other processing steps may be included in the process, such as enzymatic treatment, e.g. to remove nucleic acid, protein and/or peptidoglycan contaminants; diafiltration, e.g. to remove low molecular weight contaminants; anion exchange chromatography, e.g. to remove residual protein; and concentration. No Figure 53
Patent SG-11201407268S-A (SG)
Title: Nuclear transport modulators and uses thereof
Inventor: SANDANAYAKA VINCENT P
IPC: C07D403/12
Filed: 2013-05-09
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 14 November 2013 (14.11.2013) WIPOIPCT (10) International Publication Number WO 2013/170068 A2 (51) International Patent Classification: C07D 249/08 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/US2013/040404 9 May 2013 (09.05.2013) English English (30) Priority Data: 61/644,802 61/798,188 9 May 2012 (09.05.2012) US 15 March 2013 (15.03.2013) US (71) Applicant: KARYOPHARM THERAPEUTICS, INC. [US/US]; 2 Mercer Road, Natick, MA 01760 (US). (72) Inventors: SANDANAYAKA, Vincent, P.; 10 Laurel Av­ enue, Northboro, MA 01532 (US). SHECHTER, Sharon; 18 Ivy Lane, Andover, MA 01810 (US). SHACHAM, Sharon; 15 Bontempo Road, Newton, MA 02459 (US). MCCAULEY, Dilara; 85 Gore Street, Cambridge, MA 02141 (US). BALOGLU, Erkan; 8 Benjamin Terrace, Stoneham, MA 02180 (US). (74) Agents: ABELLEIRA, Susan, M. et al.; Hamilton, Brook, Smith & Reynolds, P.C., 530 Virginia Rd, P.O. Box 9133, Concord, MA 01742-9133 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — without international search report and to be republished upon receipt of that report (Rule 48.2(g)) (54) Title: NUCLEAR TRANSPORT MODULATORS AND USES THEREOF = FC 3 CJ oo o o l> T-H rn i-H (57) Abstract: The present invention relates to compounds of formula and pharmaceutically acceptable I: salts thereof, pharmaceut - O ical compositions comprising the compounds of formula I, and methods of using said compounds, salts and compositions in the N (I), treatment of various disorders associated with CRM1 activity.
Patent SG-11201408269P-A (SG)
Title: Nanosilica coating assembly with enhanced durability
Inventor: JING NAIYONG
IPC: C09D7/62
Filed: 2013-05-24
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 19 December 2013 (19.12.2013) WIPOIPCT (10) International Publication Number WO 2013/188083 A1 (51) International Patent Classification: C08J 7/04 (2006.01) C09D 7/12 (2006.01) C08K3/36 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/US2013/042661 24 May 2013 (24.05.2013) English English (30) Priority Data: 12171538.7 11 June 2012 (11.06.2012) EP (71) Applicant: 3M INNOVATIVE PROPERTIES COM­ PANY [US/US]; 3M Center, Post Office Box 33427, Saint Paul, Minnesota 55133-3427 (US). (72) Inventors; and (71) Applicants : JING, Naiyong [US/US]; 3M Center, Post Office Box 33427, Saint Paul, Minnesota 55133-3327 (US). STRERATH, Christiane [DE/DE]; Carl-Schurz- Strassse 1, 41453 Neuss (DE). JOST, Michael [DE/DE]; Carl-Schurz-Strasse 1, 41453 Neuss (DE). (74) Agents: NOWAK, Sandra K. et al.; 3M Center Office of Intellectual Property Counsel Post Office Box 33427, Saint Paul, Minnesota 55133-3427 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) m oo o 00 00 i-H o CJ (54) Title: NANOSILICA COATING ASSEMBLY WITH ENHANCED DURABILITY (57) Abstract: The present disclosure relates to a silica nanoparticle coating assembly having enhanced durability and articles bear­ ing silica nanoparticle coating assemblies thereon. The present disclosure is also directed to a method for enhancing abrasion resist­ ance of coating comprising acid-sintered nanosilica a particles coated onto substrate. a
Patent SG-11201906313S-A (SG)
Title: A polypeptide linker for preparing multispecific antibodies
Inventor: ZHUKOVSKY EUGENE
IPC: C07K16/28
Filed: 2018-01-09
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 12 July 2018 (12.07.2018) WIP0 1 PCT omit VIII °nolo om olo ioo Imo 1111111 ois (10) International Publication Number WO 2018/127608 Al (51) International Patent Classification: C07K 16/46 (2006.01) C07K 16/28 (2006.01) A61K 47/68 (2017.01) C07K 16/32 (2006.01) (21) International Application Number: PCT/EP2018/050481 (22) International Filing Date: 09 January 2018 (09.01.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 17305022.0 09 January 2017 (09.01.2017) EP (71) Applicant: BIOMUNEX PHARMACEUTICALS [FR/FR]; 113 me de la Tour, 75116 PARIS (FR). (72) Inventors: ZHUKOVSKY, Eugene; 5 avenue Fremiet, 75016 Paris (FR). LEGER, Olivier; 603 Route des Luches, 74800 Saint Sixt (FR). (74) Agent: CABINET BECKER ET ASSOCIES; 25, rue Louis le Grand, 75002 PARIS (FR). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) with sequence listing part of description (Rule 5.2(a)) 00 O N 1-1 1-1 (54) Title: A POLYPEPTIDE LINKER FOR PREPARING MULTISPECIFIC ANTIBODIES (57) : The present invention relates to a mutant polypeptide linker for preparing multispecific antibodies, said multispecific 0 antibodies, and methods for producing said multispecific antibodies.